HORIBA Medical has over 1,100 employees across its sites and subsidiaries. It produces 7,500 instruments a year and it is now over 10,000 tons of reagents produced annually.
HORIBA Medical also benefits from technologies patented by the HORIBA Group and the synergies between its 13 research centers throughout the world.


Since joining the Japanese Group HORIBA in 1996, company sales has continued to grow exponentially to reach €144.8 million in 2011.

 

 

Key indicators

  • Over 1,100 employees
  • 4 production centers (Japan, China, France, Brazil)
  • 2 R&D centers (Japan, France)
  • Around 100 distributors
  • 13 local/direct operations
  • Around 30,000 laboratories supplied worldwide
Biological markers for screening

25 Jun 2020 - How routinely measured biological markers could contribute to the monitoring of Coronavirus...

Read more

World Blood Cancer Day

28 May 2020 - HORIBA UK Limited is raising awareness of the World Blood Cancer Day and shows support to people...

Read more

Microsemi CRP

26 May 2020 - Microsemi CRP haematology analysers installed during COVID-19 ‘lockdown’ in POC locations to reduce...

Read more